Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. User evaluation of the DEMentia-specific Digital Interactive Social Chart (DEM-DISC). A pilot study among informal carers on its impact, user friendliness and, usefulness

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Aging & mental health 2010-05-01 Digital health tools

    The positive effects might be caused by the systematic and tailored individual way of information provisioning by DEM-DISC.

    Why it matters

    In a pilot study, 14 informal carers who could access the DEM-DISC system at home for two months reported more met and less unmet needs, and carers in the experimental group reported higher levels of competence than controls, though they were not explicitly satisfied with the first prototype. This is a small pilot study of an information tool and does not test treating, curing or preventing Alzheimer's disease.

  2. Sleep disorders in aging and dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The journal of nutrition, health & aging 2010-03-01 Mild cognitive impairment

    This paper reviews the characteristics of sleep disorders found in people at a greater risk of dementia: the elderly adult, patients with mild cognitive impairment (MCI) and those with neurodegenerative diseases.

    Why it matters

    This review describes sleep disorders in older adults, people with mild cognitive impairment, and people with neurodegenerative diseases, noting that poor sleep increases the risk of health problems and caregiver stress. It does not report any treatment, cure, or prevention of Alzheimer's disease.

  3. Characteristics of Medicare Part D Beneficiaries Who Reach the Drug Benefit Threshold in Both of the First Two Years of the Part D Benefit

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Medical Care 2010-02-19 Health systems and care delivery

    Those who reached the DBT in both years had higher morbidity and utilization.

    Why it matters

    This study found that Medicare beneficiaries who repeatedly reached the drug benefit threshold were more likely to have conditions including dementia and to use trade-name medications with limited generic alternatives. It addresses medication costs in dementia but does not test any treatment, cure, or prevention for Alzheimer's disease.

  4. Diet and neurocognition: review of evidence and methodological considerations

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Current aging science 2010-02-01 Prevention trials

    The relationship between diet and cognitive function has been a topic of increasing interest, as numerous studies have shown that variations in dietary practices and nutrient intake may protect against age-related cognitive decline, as well as the development of dementia and Alzheimer's Disease (AD).

  5. Ageing, neurodegeneration and Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Age and ageing 2010-01-05 Risk factors

    Age is the largest risk factor for the development and progression of Parkinson's disease (PD).

    Why it matters

    This review states that age is the largest risk factor for Parkinson's disease and that ageing may increase the risk of developing dementia in Parkinson's disease. It describes how ageing affects disease presentation but does not test any treatment, cure, or prevention for Alzheimer's disease.

  6. Targets for the prevention of dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease : JAD 2010-01-01 Prevention trials

    The prevalence of dementia is expected to increase dramatically over the upcoming decades due to the aging population.

  7. Hippocampal correlates of pain in healthy elderly adults: a pilot study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurology 2009-11-01 Brain scans and imaging

    Older adults who report more severe acute or chronic pain have smaller hippocampal volumes and lower levels of hippocampal N-acetylaspartate/creatine, a marker of neuronal integrity.

    Why it matters

    In this small pilot study of 20 nondemented older adults, smaller hippocampal volume was associated with higher bodily pain ratings and lower hippocampal NAA/Cr was associated with higher acute pain severity. This concerns pain and the hippocampus in healthy elderly adults, not treating, curing or preventing Alzheimer's disease.

  8. Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of geriatric psychiatry 2009-03-01 Clinical safety

    Mild AD significantly impaired simulated driving fitness, while MCI limitedly affected driving performance.

  9. Challenges for professional care of advanced dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of nursing practice 2009-02-01 End-of-life care

    Qualitative methodology based on action research identified challenges when caring for persons with advanced dementia, as perceived by key professional providers.

  10. Brain behavior relationships among African Americans, whites, and Hispanics

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer disease and associated disorders 2008-10-01 Disparities

    Hispanic subjects were, on average, significantly younger and had less years of education than African Americans or whites.

    Why it matters

    Clinical dementia diagnoses were associated with consistent differences in brain structure on MRI across African American, white, and Hispanic participants. This helps validate diagnostic assessment across diverse groups but does not treat, cure, or prevent dementia.

  11. Attitudes and support needs of Black Caribbean, south Asian and White British carers of people with dementia in the UK

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The British journal of psychiatry : the journal of mental science 2008-09-01 Disparities

    The findings suggest that specific cultural attitudes towards the caregiving role have important implications for how carers can best be supported.

    Why it matters

    This qualitative study found that Black Caribbean, south Asian, and White British carers held traditional or non-traditional caregiver ideologies that shaped their feelings of fulfilment, strain, fears, and attitudes toward formal services. It suggests cultural attitudes matter for how carers can best be supported, not for treating or preventing dementia.

  12. Exposure to antipsychotics and risk of stroke: self controlled case series study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. BMJ (Clinical research ed.) 2008-08-28 Vascular contributions

    All antipsychotics are associated with an increased risk of stroke, and the risk might be higher in patients receiving atypical antipsychotics than those receiving typical antipsychotics.

  13. Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Clinical neuropsychologist 2008-06-10 Digital health tools

    The Cache County Study of Memory in Aging (CCMS) is an epidemiological study of Alzheimer's disease (AD), mild cognitive disorders, and aging in a population of exceptionally long-lived individuals (7th to 11th decade).

    Why it matters

    In older people without dementia, advanced age and low education were linked to lower test scores across nearly all neurocognitive measures, while APOE epsilon4 had negligible and inconsistent effects once age and education were controlled. This provides information about normal cognition in advanced age rather than a treatment, cure or prevention for Alzheimer's disease.

  14. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuroradiology 2008-04-15 Hippocampus size on brain scans

    The automated hippocampal volumetric methods showed good agreement with manual hippocampal volumetry, but the volume measured using FreeSurfer was 35% larger and the agreement was questionable with IBASPM.

  15. The 'natural' endpoint of dementia: death from cachexia or dehydration following palliative care?

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of geriatric psychiatry 2007-04-01 End-of-life care

    Patients who survive to the final phase of dementia are more likely to die from cachexia or dehydration than those who die before.

  16. The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Psychiatry research 2007-03-28 Hippocampus size on brain scans

    In aged and pathological populations, reduced hippocampal volume is frequently described in association with impairment of hippocampus-dependent cognitive processes and chronically elevated cortisol levels.

  17. Maternal care modulates the relationship between prenatal risk and hippocampal volume in women but not in men

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2007-03-01 Hippocampus size on brain scans

    Smaller hippocampal volume is associated with psychiatric disorders.

  18. The many faces of corticobasal degeneration

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Parkinsonism & related disorders 2007-01-01 Digital health tools

    Corticobasal degeneration (CBD) has characteristic neuropathological features, but is a clinically heterogeneous disorder.

    Why it matters

    This review describes the clinical heterogeneity of corticobasal degeneration, noting that the corticobasal syndrome is not specific for its pathology and that patients with this syndrome could potentially be candidates for therapies aiming to modify tau biochemistry. It does not itself test any treatment, cure or prevention.

  19. Dysphagia in patients with frontotemporal lobar dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Archives of neurology 2007-01-01 Clinical safety

    When assessed via instrumentation, swallowing abnormalities are found in many patients with FTLD.

  20. Spatial memory and hippocampal volume in humans with unilateral vestibular deafferentation

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Hippocampus 2007-01-01 Hippocampus size on brain scans

    Patients with acquired chronic bilateral vestibular loss were recently found to have a significant impairment in spatial memory and navigation when tested with a virtual Morris water task.

  21. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Acta neuropathologica 2006-12-30 Disease mechanisms

    Hippocampal sclerosis (HS) is characterized by selective neuronal loss and gliosis in CA1 and the subiculum and has been associated with several disorders, including Alzheimer's disease, frontotemporal lobar degeneration with ubiquitin immunoreactive inclusions (FTLD-U), vascular dementia and some tauopathies.

  22. The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Australian and New Zealand journal of psychiatry 2006-11-01 Cognitive tests and assessment

    The NUCOG was undertaken with the MMSE on a total of 347 individuals, with 82 subjects in the control group and 265 in the patient group.

    Why it matters

    This study examined the validity and reliability of a brief cognitive screen, the NUCOG, in 347 people including patients with dementia, psychiatric illness and neurological disorders, and compared it with the MMSE. It is about a screening tool, not a treatment or cure.

  23. Diabetes mellitus and dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Diabetes & metabolism 2006-11-01 Vascular contributions

    Alzheimer's disease (AD) and diabetes mellitus (DM) are two of the most common and devastating health problems in the elderly.

  24. Satisfaction with end-of-life care for nursing home residents with advanced dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of the American Geriatrics Society 2006-10-01 End-of-life care

    Better communication, greater resident comfort, no tube feeding, and care in a specialized dementia unit are modifiable factors that may improve satisfaction with care in advanced dementia.

  25. Increased fMRI responses during encoding in mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurobiology of aging 2006-09-25 Hippocampus size on brain scans

    Structural and functional magnetic resonance imaging (fMRI) was performed on 21 healthy elderly controls, 14 subjects with mild cognitive impairment (MCI) and 15 patients with mild Alzheimer's disease (AD) to investigate changes in fMRI activation in relation to underlying structural atrophy.

From across this topic

10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics